Visit Aggrego Advances hub to learn more about the late breaking developments from the POSEIDON trial 

Click Here
Saturday
June
03
Top Stories
syringe and pills
Janssen Presents Longer-Term Talquetamab Follow-Up Data Showing Overall Response Rates of More Than 70 Percent in Heavily Pretreated Patients With Multiple Myeloma

On June 3rd, Johnson & Johnson announced updated results from the pivotal Phase 1/2 MonumenTAL-1 study of the investigational bispecific antibody talquetamab in the treatment of patients with r

PR Newswire
Janssen Presents First-ever Results from Dual Bispecific Combination Study Showing 96 Percent Overall Response Rate in Patients With Relapsed or Refractory Multiple Myeloma

According to data presented at ASCO 2023 on June 3rd, the Janssen Pharmaceutical Companies of Johnson & Johnson announced the first-ever results from the Phase 1b RedirecTT-1 study of teclistam

Janssen
red blood cells
Phase 1 Trial of KN046, a Novel Bispecific Antibody Targeting PD-L1 and CTLA-4 in Patients With Advanced Solid Tumors

Phase 1 clinical trial results demonstrate that in patients with nasopharyngeal carcinoma, EGFR-mutated non-small cell lung cancer, and other advanced soli

Journal for ImmunoTherapy of Cancer
medicine

Spotlight

Late-Breaking Developments From the POSEIDON Trial

Results of late-breaking developments from the POSEIDON Phase III trial revealed improved overall survival with a limited course of five cycles of tremelimumab added to durvalumab plus platinum chemotherapy. 

Breast Cancer
More
HD201 Comparable to Referent Trastuzumab for HER2-Positive Breast Cancer
Oncology Learning Network
Female doctor reading an article on a tablet.
Epigenetic Aging in Older Breast Cancer Survivors and Non-cancer Controls: Preliminary Findings From the Thinking and Living With Cancer (TLC) Study
Cancer
blood tubes in a lab for research.
High BMI Impacts Survival in Younger Patients With Breast Cancer
Medscape
A blue tape measure lying on a bathroom scale.
GE Health Care Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
businesswire
Digital rendering of a breast cancer tumor highlighted orange.
Artificial Intelligence from ScreenPoint Medical and Volpara Health Demonstrates Ability to Predict Long-Term Breast Cancer Risk
PR Newswire
Male doctor and female doctor sitting at a computer talking.
Physician Knowledge and Attitudes Toward Breast Cancer Screening Strategies in Transgender Population
MedPage Today
Testing for ESR1 Mutations to Guide Therapy for HR+, HER- Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update
Journal of Clinical Oncology
Digital rendering of a human body with a breast cancer tumor highlighted orange.
PREDICT Validity for Prognosis of Breast Cancer Patients With Pathogenic BRCA1/2 Variants
npj breast cancer
Female doctor and patient sitting at a desk looking at a chart.
Treatment Disparities in Radiation and Hormone Therapy Among Women Covered by Medicaid vs Private Insurance in Cancer Registry and Claims Data
JAMA Health Forum
Closeup of an African American doctor's hands at a computer.
Lung Cancer
More
Calviri Scientists Find New Class of Biomarkers for Predicting Treatment Response in Cancer Patients
PR Newswire
blood tubes in a lab for research.
Stereotactic Ablative Radiotherapy Before Resection to Avoid Delay for Early-stage Lung Cancer or Oligometastases During the COVID-19 Pandemic
Cancer
tomography
The Association of Organizational Readiness With Lung Cancer Screening Utilization
American Journal of Preventive Medicine
lungs
Osimertinib Plus Chemotherapy Demonstrated Strong Improvement in PFS for Patients with EGFR-mutated Advanced Lung Cancer in FLAURA2 Phase 3 Trial
businesswire
prescription medication in a pharmacy
Goals and Goal Perceptions in Patients With Advanced Stage Lung Cancer
Supportive Care in Cancer
pediatric patient
Common Genetic Variations in Telomere Length Genes and Lung Cancer
eLife
Computer graphic illustration of blue and green circuits.
Pragmatica-Lung Study Aims to Increase Accessibility to Cancer Clinical Trials
News-Medical
woman in lab
Everyday Diet Choices Impact Lung Cancer Risk Far Greater Than Americans Suspect
Aggrego Oncology
Reducing Anxiety and Dyspnea via Device-guided Breathing
Integrative Cancer Therapies
Lung Breathing Device

Start your day with an email
that tells you what’s happening
and why it matters.

sign up
Doctor
News
FDA Approvals
More
ABK Biomedical Announces FDA IDE Approval for a Multi-Center Pivotal Study of Eye90 Microspheres® in Hepatocellular Carcinoma
PR Newswire
Male doctor and female doctor sitting at a computer talking.
Antengene Announces Claudin 18.2 Antibody-Drug Conjugate ATG-022 Granted Orphan Drug Designations by the US FDA for the Treatment of Gastric and Pancreatic Cancers
PR Newswire
GI system
IDEAYA Announces IND Clearance Enabling Phase 1/2 Clinical Trial for Combination of IDE397 and AMG 193 in MTAP-deletion Solid Tumors
PR Newswire
Digital rendering of human torso with gastrointestinal system highlighted red.
HanX Biopharmaceuticals Announces HX009 IND Approval From FDA
PR Newswire
A patient touching a dextrose bag hanging from an IV cart.
Lumicell Announces FDA Acceptance and Priority Review of New Drug Application for LUMISIGHT™ Optical Imaging Agent for Breast Cancer
businesswire
Digital rendering of a breast cancer tumor highlighted orange.
Epcoritamab-bysp Approved by US FDA as the First and Only Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
AbbVie
medicine
Indapta Therapeutics Announces US FDA Clearance of IND for IDP-023, an Allogeneic Natural Killer (NK) Cell Therapy for Cancer
businesswire
Blood Cells Circulating Throughout the Body
FDA Approval, Clinical Trial Evidence, Efficacy, Epidemiology, and Price for Non-orphan and Ultra-rare, Rare, and Common Orphan Cancer Drug Indications
BMJ
Female doctor and patient sitting at a desk looking at a chart.
FDA Declines to Approve ImmunityBio's Bladder Cancer Therapy, Shares Slump
Reuters
Closeup of a doctor looking at a spreadsheet on a clipboard.